Company:  AVADEL PHARMACEUTICALS PL ... (AVDL)
Form Type:  4
Filing Date:  7/11/2018 
CIK:  0001012477 
Address:  BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
BALLYCOOLIN
 
City, State, Zip:  DUBLIN,  15 
Telephone:  636-449-1830 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$3.57  
Change: 
0.08 (2.29%)  
Trade Time: 
11:05 AM EST  
Market Cap: 
$143.10M
Trade AVDL now with 

© 2018  
Description of Business
(Dollar amounts in thousands, except per-share amounts and as otherwise noted) General Overview Avadel Pharmaceuticals plc ("Avadel," the "Company," "we," "our," or "us") is a branded specialty pharmaceutical company. Avadel's current revenues are primarily derived from products we market based on first-to-file New Drug Applications ("NDAs") for pharmaceutical products previously sold in the U.S. without Food and Drug Administration ("FDA") approval ("Unapproved Marketed Products" or "UMDs"). In addition, through the acquisition of patient-focused, innovative products or businesses in the commercial- and or late-stage of development, Avadel seeks to provide solutions for overlooked and unmet medical needs, including our urology product, Noctiva(TM), which we in-licensed in 2017 and will begin marketing in 2018. Avadel also seeks to develop products that utilize our Micropump® drug delivery technology, such as our narcolepsy product which is in clinical trials.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES